239 related articles for article (PubMed ID: 8390666)
1. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.
Szekely L; Selivanova G; Magnusson KP; Klein G; Wiman KG
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5455-9. PubMed ID: 8390666
[TBL] [Abstract][Full Text] [Related]
2. Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns.
Szekely L; Pokrovskaja K; Jiang WQ; Selivanova G; Löwbeer M; Ringertz N; Wiman KG; Klein G
Oncogene; 1995 May; 10(9):1869-74. PubMed ID: 7753563
[TBL] [Abstract][Full Text] [Related]
3. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
Tong X; Yalamanchili R; Harada S; Kieff E
J Virol; 1994 Oct; 68(10):6188-97. PubMed ID: 8083959
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays.
Inman GJ; Farrell PJ
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2141-9. PubMed ID: 7561751
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies.
Szekely L; Pokrovskaja K; Jiang WQ; de The H; Ringertz N; Klein G
J Virol; 1996 Apr; 70(4):2562-8. PubMed ID: 8642686
[TBL] [Abstract][Full Text] [Related]
6. The Epstein-Barr virus nuclear antigen leader protein associates with hsp72/hsc73.
Mannick JB; Tong X; Hemnes A; Kieff E
J Virol; 1995 Dec; 69(12):8169-72. PubMed ID: 7494344
[TBL] [Abstract][Full Text] [Related]
7. Protein-protein interactions between Epstein-Barr virus nuclear antigen-LP and cellular gene products: binding of 70-kilodalton heat shock proteins.
Kitay MK; Rowe DT
Virology; 1996 Jun; 220(1):91-9. PubMed ID: 8659132
[TBL] [Abstract][Full Text] [Related]
8. Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion.
Szekely L; Jiang WQ; Pokrovskaja K; Wiman KG; Klein G; Ringertz N
J Gen Virol; 1995 Oct; 76 ( Pt 10)():2423-32. PubMed ID: 7595346
[TBL] [Abstract][Full Text] [Related]
9. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693
[TBL] [Abstract][Full Text] [Related]
10. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
11. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
Maunders MJ; Petti L; Rowe M
J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
Cohen JI; Picchio GR; Mosier DE
J Virol; 1992 Dec; 66(12):7555-9. PubMed ID: 1331538
[TBL] [Abstract][Full Text] [Related]
13. Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association.
Tanaka M; Yokoyama A; Igarashi M; Matsuda G; Kato K; Kanamori M; Hirai K; Kawaguchi Y; Yamanashi Y
J Virol; 2002 Feb; 76(3):1025-32. PubMed ID: 11773378
[TBL] [Abstract][Full Text] [Related]
14. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the Epstein-Barr virus nuclear antigen 2 by far-Western blotting and DNA-binding studies.
Sauder C; Götzinger N; Schubach WH; Horvath GC; Kremmer E; Krebs A; König S; Zimber Strobl U; Mueller Lantzsch N; Grässer FA
J Gen Virol; 1996 May; 77 ( Pt 5)():991-6. PubMed ID: 8609497
[TBL] [Abstract][Full Text] [Related]
16. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
17. Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5.
Jiang WQ; Szekely L; Wendel-Hansen V; Ringertz N; Klein G; Rosén A
Exp Cell Res; 1991 Dec; 197(2):314-8. PubMed ID: 1659990
[TBL] [Abstract][Full Text] [Related]
18. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
Schaefer BC; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1.
Matsuda G; Nakajima K; Kawaguchi Y; Yamanashi Y; Hirai K
Microbiol Immunol; 2003; 47(1):91-9. PubMed ID: 12636258
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
Sample C; Parker B
Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
